Ces1 has been recently shown to be protective from liver inflammation and injury (Xu et al., 2016), and its hepatic deficiency strongly increases susceptibility to cholesterol-driven liver injury (Li et al., 2017). This evidence concerns the gene CES1 and hyperinsulinemic hypoglycemia, familial, 4.